May 14, 2024 | Cancer Center News
Cancer Center at Illinois (CCIL) member Hua Wang, professor of materials science and engineering, published new research in Materials Today Bio demonstrating the development of a novel technology to prevent post-surgical recurrence of breast cancer, especially...
Apr 25, 2024 | Cancer Center News
The CCIL was featured on WCIA during Testicular Cancer Awareness Month. CCIL member Michael Spinella shared the results of his lab’s testicular cancer research, including the development of epigenetic drugs to help patients who don’t respond to...
Apr 24, 2024 | Cancer Center News
Testicular cancer is a rare form of one of the world’s most devastating diseases. Most cases respond well to conventional treatments, but a team affiliated with the Cancer Center at Illinois (CCIL) has spent years working on ways to help patients who don’t have that...
Apr 24, 2024 | Cancer Center News, CCIL Shared Resources
The Tumor Engineering and Phenotyping (TEP) facility, a Cancer Center at Illinois (CCIL) shared resource, is here to accelerate your discoveries with the addition of a new instrument for nanoparticle synthesis. The PreciGenome NanoGenerator™ Flex-M utilizes a...
Feb 29, 2024 | Cancer Center News
Cancer Center at Illinois (CCIL) member Jeff Chan, associate professor of chemistry, recently published research demonstrating the development of an activatable cancer therapeutic to help eliminate the side effects of traditional chemotherapies. “There are many potent...
Jan 8, 2024 | Cancer Center News
Cancer Center at Illinois (CCIL) Deputy Director Paul Hergenrother was recently named a 2023 National Cancer Institute (NCI) Outstanding Investigator. The prestigious NCI Outstanding Investigator Award (OIA) recognizes the outstanding research performance of cancer...
Nov 21, 2023 | Cancer Center News
Cancer Center at Illinois (CCIL) researchers David Shapiro and Paul Hergenrother Estrogen receptor-positive breast cancer is the most common form of breast cancer, affecting approximately 75% of breast cancer patients. In advanced and metastatic form, it is lethal,...
Jul 20, 2023 | Cancer Center News
Cancer Center at Illinois members Joonsu Han (left), Hua Wang (center), and Rhimsha Bhatta. Researchers in Cancer Center at Illinois (CCIL) member Hua Wang’s lab continue to pioneer novel technologies that enhance the efficacy of cancer immunotherapies. The latest...
Feb 21, 2023 | Cancer Center News
Cancer Center at Illinois researcher Erik Nelson, professor of molecular and integrative physiology in the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign, considers this moment “a milestone” in his career. Several...
Jan 10, 2023 | Cancer Center News
Illinois professor of veterinary clinical medicine Dr. Timothy Fan, left, and chemistry professor Paul Hergenrother. The U. of I. team found that the compound PAC-1 has therapeutic potential in pet dogs with spontaneously occurring cancers. The animal studies set the...
Nov 15, 2022 | Cancer Center News
Urbana, Ill. – For decades, bright fluorescent cyanine dyes have been used in a variety of medical procedures, like identifying the sentinel lymph nodes where cancer cells might spread or identifying cancerous tumors in fluorescence-guided surgery. Though widely...
Jul 28, 2022 | Cancer Center News
Timothy Fan and Paul Hergenrother. Urbana, Ill. – Cancers that begin in the brain, or start elsewhere in the body and spread to it, are notoriously difficult to treat. Illinois researchers in Cancer Center at Illinois labs are looking to improve those odds by...
